Massachusetts General Hospital is launching Boston’s second hand transplant program, hoping eventually to pioneer a new way of replacing patients’ limbs without subjecting them to a lifetime of dangerous antirejection drugs - an advance that could turn a rare operation into a routine one. Curtis Cetrulo, MGH Instructor in Surgery, Peter Slavin, MGH CEO, and Michael Zinner, head of the department of Surgery at Brigham and Women’s Hospital, are quoted.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?